Try our Advanced Search for more refined results
March 14, 2022
Deputy v. Akebia Therapeutics, Inc. et al
Case Number:
1:22-cv-01411
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 15, 2022
Akebia Hit With Investor Suit Over Anemia Drug Disclosure
Kidney drug company Akebia Therapeutics Inc. is facing a shareholder suit that accuses it of misrepresenting the regulatory approval chances for an anemia therapy it had in the works, which an investor said pushed down trading prices for the company's shares by nearly 75%.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login